Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pamiparib consolidation in LS-SCLC
NCT05483543Phase 2Unknown
- Sponsor
- Fudan University
- Start
- Jun 2022
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pamiparib in small cell lung cancer (SCLC), sponsored by Fudan University. Status: unknown.
02
Drugs
pamiparib
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT05483543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05483543.